Tag

Tagged: cancer genome

Sponsored

Dame Deborah James, who died aged 40 of bowel cancer, spent the last 5 years of her life raising awareness about her type of cancer, but also fighting to make personalised medicine more widely available for cancer patients.

Personalized medicine is therapy customized for an individual and has become more readily available as the cost of gene sequencing has been significantly reduced. An example is when treatment is targeted to a specific type of cancer cells.

HealthPad had partnered with a consortium of leading cancer specialists to explain what personalised medicine means and what it can do for cancer patients.

The HealthPad Team would like to join the many people who have admired Dame Deborah for her courage and determination.

Thank you and farewell, BowelBabe.

#bowelbabe #damedeborahjames #personalisedmedicine

go to cluster
view in full page
joined 10 years, 10 months ago

James Brenton

Senior group leader, Cancer Research UK (CR-UK) Cambridge Institute and lead, Functional Genomics of Ovarian Cancer laboratory

James D. Brenton is a senior group leader at the Cancer Research UK (CR-UK) Cambridge Institute and leads the Functional Genomics of Ovarian Cancer laboratory. He qualified in medicine from University College London in 1988 and trained in medical oncology at the Royal Marsden Hospital, Princess Margaret Hospital, Toronto and the Department of Oncology, University of Cambridge. He has been an honorary consultant in medical oncology at Cambridge University Hospitals NHS Foundation Trust since 2001. His PhD work was carried out at the Wellcome Trust/Cancer Research UK Gurdon Institute of Cancer and Developmental Biology and he held a Cancer Research UK Senior Clinical Research Fellow from 2001–2006 at the Hutchison/MRC Research Centre.

His research focuses on the identification of prognostic and predictive markers for therapy in ovarian cancer and identifying mechanisms of drug resistance, with particular emphasis on the genomic profiling of clinical samples and bioinformatic analysis.

He is the chair of the Informatics Advisory Group for the national CR-UK Stratified Medicine Programme and was previously Vice-Chair of the CR-UK Biomarkers and Imaging Discovery and Development Committee. He is a member of the international Ovarian Tumor Tissue Analysis (OTTA) Consortium project approval committee, the SGCTG Protocol Review Committee, NCRI ovarian cancer subgroup and the CR-UK Clinical Fellows Mentor Panel.


view this profile
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page

Click here to find out more about The Cancer Genome Atlas project

Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page